The Company has research interests in protein markers, subcellular pathology, cell death, cell proliferation, clinical models, genetic expression, assays, and development. Nymox participates and takes great interest in scientific collaborations, working together with prominent international researchers.
Nymox works exclusively with proprietary inventions and has acquired several hundred global applications and issued patents covering a wide range of fields and applications.
Benign Prostate Hyperplasia
BPH, one of the most commonly diagnosed diseases in the male population
Fexapotide for BPH
For the treatment of Benign Prostate Hyperplasia (BPH)